Efficacy and safety of enavogliflozin versus dapagliflozin added to metformin plus gemigliptin treatment in patients with type 2 diabetes: A double-blind, randomized, comparator-active study: ENHANCE-D study
- ENHANCE-D Investigators
- CHA University
- Eulji University
- Inje University
- Kangbuk Samsung Hospital
- Hanyang University
- Chosun University
- Daejin Medical Center
- Konkuk University
- Yonsei University
- Jeju National University
- Hallym University
- Keimyung University
- Sungkyunkwan University
- Korea University
- Soonchunhyang University
- Myongji Hospital
- Seoul National University
- Pusan National University
- Seoul Medical Center
- Yeungnam University
- Gachon University
- The Catholic University of Korea
- Central Hospital
- Inha University
- Daewoong Pharmaceutical Co., Ltd.
Research output: Contribution to journal › Article › peer-review
16
Link opens in a new tab
Scopus
citations